loader from loading.io

JAMA Highlights From ESC 2024

JAMA Clinical Reviews

Release Date: 09/02/2024

Mpox Treatment Strategies, Clinical Presentation, and Diagnostic Approaches show art Mpox Treatment Strategies, Clinical Presentation, and Diagnostic Approaches

JAMA Clinical Reviews

Mpox is an evolving global health threat, and clinicians should be aware of characteristic signs and symptoms to ensure timely diagnosis and appropriate management. Author Jason Zucker, MD, MS, of Columbia University Irving Medical Center...

info_outline
Calcific Aortic Stenosis: Symptoms, Diagnosis, and Treatment show art Calcific Aortic Stenosis: Symptoms, Diagnosis, and Treatment

JAMA Clinical Reviews

Calcific aortic stenosis affects approximately 12% of people >75 years in the US and worldwide leads to more than 100 000 deaths each year. Catherine M. Otto, MD, PhD, of the University of Washington School of Medicine, Seattle,...

info_outline
CAR T Cells and T-Cell Therapies for Cancer show art CAR T Cells and T-Cell Therapies for Cancer

JAMA Clinical Reviews

CAR T cells are genetically engineered to express a receptor that recognizes and kills tumor cells. CAR T-cell products are now FDA approved for 6 hematologic malignancies. Author Jennifer N. Brudno, MD, National Cancer Institute, joins...

info_outline
Diagnosis and Treatment of Peptic Ulcer Disease show art Diagnosis and Treatment of Peptic Ulcer Disease

JAMA Clinical Reviews

Peptic ulcer disease affects approximately 1% of the population in the US, and H pylori is a common cause of peptic ulcer disease. Author Nimish Vakil, MD, a gastroenterologist from the University of Wisconsin, Madison, discusses current...

info_outline
Strategies for Helping Patients Navigate High Prescription Drug Costs show art Strategies for Helping Patients Navigate High Prescription Drug Costs

JAMA Clinical Reviews

High prescription costs are a major barrier to the optimal treatment of many health conditions. Prescribers need tools to help patients find the lowest drug costs. Author Hussain S. Lalani, MD, MPH, MSc, of Brigham and Women's Hospital and...

info_outline
Preexposure Prophylaxis (PrEP) Options for HIV show art Preexposure Prophylaxis (PrEP) Options for HIV

JAMA Clinical Reviews

Even though highly effective medications are currently available to prevent HIV, there are about 1.3 million new infections worldwide each year. Monica Gandhi, MD, MPH, of the University of California San Francisco joins JAMA Senior Editor...

info_outline
Update on Over-the-Counter (OTC) Contraception show art Update on Over-the-Counter (OTC) Contraception

JAMA Clinical Reviews

In July 2023, the US Food and Drug Administration (FDA) approved Opill, a daily progestin-only oral contraceptive for over-the-counter sale to people of all ages. Daniel Grossman, MD, discusses this and more with JAMA Associate Editor...

info_outline
Dialysis for Chronic Kidney Failure show art Dialysis for Chronic Kidney Failure

JAMA Clinical Reviews

Selection of hemodialysis or peritoneal dialysis and timing of dialysis initiation are influenced by patient symptoms, laboratory trajectories, patient preferences, and therapy cost and availability; shared decision-making is key. Jennifer...

info_outline
Diagnosis and Treatment of Chronic Spontaneous Urticaria show art Diagnosis and Treatment of Chronic Spontaneous Urticaria

JAMA Clinical Reviews

Chronic spontaneous urticaria affects approximately 1% of the general population worldwide, impairs patients’ quality of life, and is associated with multiple comorbidities. Pavel Kolkhir, MD, discusses the current evidence on the...

info_outline
Diagnosis and Treatment of Community-Acquired Pneumonia (CAP) show art Diagnosis and Treatment of Community-Acquired Pneumonia (CAP)

JAMA Clinical Reviews

Community-acquired pneumonia is associated with approximately 740 000 hospitalizations and 41 000 deaths in the US annually. JAMA Review authors Scott A. Flanders, MD, and Valerie M. Vaughn, MD, MSc, discuss diagnosis and treatment of community-acquired pneumonia with JAMA Deputy Editor Mary McGrae McDermott, MD. Related Content:

info_outline
 
More Episodes

JAMA Editor in Chief Kirsten Bibbins-Domingo reviews 4 JAMA trials presented at this year’s European Society of Cardiology (ESC) Congress on antihypertensive continuation before elective surgery, potassium supplementation after cardiac surgery, pulmonary vein isolation for symptomatic atrial fibrillation, and a triple-drug combination pill for resistant hypertension in Africa.

Correction: an earlier version of this podcast contained an error in the conclusion of the TIGHT K trial summary, which has been updated.

Related Content: